SUBSCRIBE
SUBSCRIBE

No Heart Risk Seen With Pfizer COPD Drug - FDA

January 15, 2010 | 
1 min read
Reuters -- U.S. health officials on Thursday said they found no increased risk of heart trouble with use of Pfizer Inc's (PFE.N) inhaled lung drug Spiriva.